Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -3.63% | 62.61 | 0.0% | $958.21m | |
| NVAX | Novavax, Inc. | -2.02% | 94.36 | 251.8% | $764.51m | |
| AMGN | Amgen, Inc. | -1.04% | 249.04 | 1.3% | $693.79m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -3.09% | 620.86 | 2.5% | $663.02m | |
| GILD | Gilead Sciences, Inc. | 2.16% | 76.32 | 1.0% | $630.80m | |
| BIIB | Biogen, Inc. | 0.07% | 278.88 | 1.6% | $601.57m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.32% | 294.45 | 1.9% | $475.52m | |
| ILMN | Illumina, Inc. | -0.63% | 370.25 | 3.5% | $301.18m | |
| VXRT | Vaxart, Inc. | -2.56% | 7.98 | 0.0% | $286.91m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.32% | 108.82 | 2.0% | $217.19m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.59% | 126.06 | 4.3% | $206.81m | |
| SRNE | Sorrento Therapeutics, Inc. | 4.00% | 8.06 | 1.8% | $192.86m | |
| SGEN | Seattle Genetics, Inc. | -3.76% | 174.35 | 6.1% | $192.39m | |
| IMMU | Immunomedics, Inc. | -2.32% | 41.32 | 11.0% | $177.00m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 2.03% | 162.25 | 8.5% | $166.65m |
Company Profile
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research & Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.